Herzliya, Israel

Alex Shot

This inventor holds 1 USPTO granted patent. Top assignee: Synopsys, Inc.. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alex Shot - Innovator in Hardware Emulation

Introduction

Alex Shot is a notable inventor based in Herzliya, Israel. He has made significant contributions to the field of hardware emulation, particularly through his innovative patent. His work focuses on enhancing the efficiency and functionality of circuit designs.

Latest Patents

Alex Shot holds a patent titled "Adding delay elements to enable mapping a time division multiplexing circuit on an FPGA of a hardware emulator." This patent presents a method for performing hardware emulation of a circuit design. The method involves partitioning a portion of the circuit design to a configurable logic chip, adding a selection circuit, and managing signal selection during clock cycles. The independent claims of this patent provide a concise description of its embodiments, showcasing the innovative approach to hardware emulation.

Career Highlights

Alex Shot is currently employed at Synopsys, Inc., where he continues to develop and refine technologies related to hardware emulation. His expertise in the field has positioned him as a valuable asset to the company and the broader technology community.

Collaborations

Some of Alex's coworkers include Nathaniel Azuelos and Daniel Geist. Their collaborative efforts contribute to the advancement of technology in hardware emulation and related fields.

Conclusion

Alex Shot's contributions to hardware emulation through his innovative patent and work at Synopsys, Inc. highlight his role as a significant inventor in the technology sector. His advancements continue to influence the development of efficient circuit designs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…